Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H21N2.Cl |
Molecular Weight | 312.836 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].CC1=C(C)[N+](CC2=CC=CC=C2)=CN1CC3=CC=CC=C3
InChI
InChIKey=ZATWGHMQWRXUNZ-UHFFFAOYSA-M
InChI=1S/C19H21N2.ClH/c1-16-17(2)21(14-19-11-7-4-8-12-19)15-20(16)13-18-9-5-3-6-10-18;/h3-12,15H,13-14H2,1-2H3;1H/q+1;/p-1
Molecular Formula | C19H21N2 |
Molecular Weight | 277.3834 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:44:02 UTC 2023
by
admin
on
Sat Dec 16 10:44:02 UTC 2023
|
Record UNII |
29S9F3SV9Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID70851687
Created by
admin on Sat Dec 16 10:44:02 UTC 2023 , Edited by admin on Sat Dec 16 10:44:02 UTC 2023
|
PRIMARY | |||
|
596093-98-0
Created by
admin on Sat Dec 16 10:44:02 UTC 2023 , Edited by admin on Sat Dec 16 10:44:02 UTC 2023
|
PRIMARY | |||
|
404702
Created by
admin on Sat Dec 16 10:44:02 UTC 2023 , Edited by admin on Sat Dec 16 10:44:02 UTC 2023
|
PRIMARY | |||
|
29S9F3SV9Q
Created by
admin on Sat Dec 16 10:44:02 UTC 2023 , Edited by admin on Sat Dec 16 10:44:02 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Results were expressed as ED50 values (ug/mL) and are as follows: human lung carcinoma(A549) >10; human bladder carcinoma(UMUC3) = >10; human colon adenocarcinoma(HT-29) >10; human prostate adenocarcinoma(PC3) >10; human pancreatic adenocarcinoma(PACA2) >10; human kidney carcinoma(A4982LM) >10; human breast carcinoma(MDA231) >10; human ovarian carcinoma(FDIGROV) = 7.39.
|